Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-01 Sale | 2024-07-03 4:05 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 25,000 | $41.18 | $1,029,535 | 2,203,345 (Direct) | View |
| 2024-06-03 Sale | 2024-06-05 4:05 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $40.61 | $2,030,520 | 2,218,055 (Direct) | View |
| 2024-05-10 Sale | 2024-05-14 5:16 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $42.1 | $2,105,125 | 2,268,055 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 4:15 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $42.33 | $2,116,640 | 2,318,055 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:15 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $41.01 | $2,050,550 | 2,368,055 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 5:49 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $41.16 | $2,057,890 | 2,418,055 (Direct) | View |
| 2024-02-07 Sale | 2024-02-08 7:19 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 2,161 | $41.54 | $89,777 | 21,431 (Direct) | View |
| 2024-02-07 Sale | 2024-02-08 7:14 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 2,506 | $41.54 | $104,110 | 61,960 (Direct) | View |
| 2024-01-02 Sale | 2024-01-04 4:15 pm | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $42.24 | $2,111,815 | 2,455,121 (Direct) | View |
| 2023-12-26 Sale | 2023-12-28 4:15 pm | Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer | 10,000 | $42.47 | $424,700 | 553,108 (Direct) | View |
| 2023-12-22 Sale | 2023-12-27 4:15 pm | Cerevel Therapeutics Holdings Inc. | CERE | DiPietro Kenneth Chief Human Resources Officer | 8,000 | $41.45 | $331,608 | 326,905 (Direct) | View |
| 2023-12-20 Sale | 2023-12-21 8:27 pm | Cerevel Therapeutics Holdings Inc. | CERE | Bodenrader Mark See Remarks | 7,889 | $41.42 | $326,788 | 17,724 (Direct) | View |
| 2023-12-20 Sale | 2023-12-21 8:24 pm | Cerevel Therapeutics Holdings Inc. | CERE | DiPietro Kenneth Chief Human Resources Officer | 6,256 | $41.42 | $259,144 | 24,663 (Direct) | View |
| 2023-12-20 Sale | 2023-12-21 8:21 pm | Cerevel Therapeutics Holdings Inc. | CERE | Akamine Scott Chief Legal Officer | 7,072 | $41.42 | $292,945 | 7,237 (Direct) | View |
| 2023-12-20 Sale | 2023-12-21 8:14 pm | Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer | 10,152 | $41.42 | $420,528 | 14,673 (Direct) | View |
| 2023-12-20 Sale | 2023-12-21 8:12 pm | Cerevel Therapeutics Holdings Inc. | CERE | ALTSCHULLER Susan Chief Financial Officer | 13,808 | $41.42 | $571,972 | 16,913 (Direct) | View |
| 2023-12-20 Sale | 2023-12-21 8:10 pm | Cerevel Therapeutics Holdings Inc. | CERE | Tregoning Kathleen See Remarks | 6,288 | $41.42 | $260,469 | 7,516 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-01 Exercise | 2024-07-03 4:05 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 25,000 | $0 | 2,203,345 (Direct) | View |
| 2024-07-01 Exercise | 2024-07-03 4:05 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 25,000 | $3.5 | 2,203,345 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:22 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Gordon Christopher R Director 10% Owner | 10,461 | $0 | 65,693,524 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:12 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner | 10,461 | $0 | 65,693,524 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:34 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 10,290 | $0 | 25,928 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:34 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director | 10,461 | $0 | 444,609 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:34 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | PATRICK DEVAL L Director | 10,461 | $0 | 13,743 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director | 10,461 | $0 | 56,553 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Giordano Douglas E. Director | 10,461 | $0 | 13,743 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:28 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Sulzberger Gabrielle Director | 10,461 | $0 | 58,876 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:27 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Mckernan Ruth Director | 10,461 | $0 | 13,743 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-05 4:05 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $0 | 2,218,055 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-05 4:05 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $3.5 | 2,218,055 (Direct) | View |
| 2024-05-10 Exercise | 2024-05-14 5:16 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $0 | 2,268,055 (Direct) | View |
| 2024-05-10 Exercise | 2024-05-14 5:16 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $3.5 | 2,268,055 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 4:15 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $0 | 2,318,055 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $3.5 | 2,318,055 (Direct) | View |
| 2024-03-04 Exercise | 2024-03-06 4:15 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $0 | 2,368,055 (Direct) | View |
| 2024-03-04 Exercise | 2024-03-06 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $3.5 | 2,368,055 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-04 5:49 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $0 | 2,418,055 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-04 5:49 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $3.5 | 2,418,055 (Direct) | View |
| 2024-02-20 Gift | 2024-02-21 4:54 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director | 170,317 | $0 | 10,794,876 (Indirect) | View |
| 2023-08-29 Ownership | 2024-02-13 4:16 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Sulzberger Gabrielle Director | 562 | $0 | 48,415 (Direct) | View |
| 2024-02-06 Exercise | 2024-02-08 7:19 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 5,020 | $0 | 21,431 (Direct) | View |
| 2024-02-06 Exercise | 2024-02-08 7:14 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 15,440 | $0 | 61,960 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-23 5:51 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | ALTSCHULLER Susan Chief Financial Officer | 81,065 | $0 | 81,065 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-23 5:50 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer | 87,573 | $0 | 87,573 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-23 5:46 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Tregoning Kathleen See Remarks | 59,171 | $0 | 59,171 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-23 5:45 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | DiPietro Kenneth Chief Human Resources Officer | 63,905 | $0 | 63,905 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-23 5:37 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Bodenrader Mark See Remarks | 24,852 | $0 | 24,852 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-23 5:37 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Burgess Paul D. See Remarks | 81,065 | $0 | 81,065 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-23 5:34 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer | 87,573 | $0 | 87,573 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-23 5:31 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renaud Ronald C JR President & CEO | 284,023 | $0 | 284,023 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-23 5:31 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Akamine Scott Chief Legal Officer | 59,171 | $0 | 59,171 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-04 4:15 pm | N/A 2028-12-24 | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $0 | 2,455,121 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-04 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director | 50,000 | $3.5 | 2,455,121 (Direct) | View |
| 2023-12-26 Exercise | 2023-12-28 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Tregoning Kathleen See Remarks | 3,150 | $10.05 | 265,748 (Direct) | View |
| 2023-12-26 Exercise | 2023-12-28 4:15 pm | N/A 2030-07-29 | Cerevel Therapeutics Holdings Inc. | CERE | Tregoning Kathleen See Remarks | 3,150 | $0 | 265,748 (Direct) | View |
| 2023-12-26 Exercise | 2023-12-28 4:15 pm | N/A 2029-02-27 | Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer | 10,000 | $0 | 553,108 (Direct) | View |
| 2023-12-26 Exercise | 2023-12-28 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer | 10,000 | $3.5 | 553,108 (Direct) | View |
| 2023-12-22 Exercise | 2023-12-27 4:15 pm | N/A 2029-04-02 | Cerevel Therapeutics Holdings Inc. | CERE | DiPietro Kenneth Chief Human Resources Officer | 8,000 | $0 | 326,905 (Direct) | View |
| 2023-12-22 Exercise | 2023-12-27 4:15 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | DiPietro Kenneth Chief Human Resources Officer | 8,000 | $3.5 | 326,905 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 8:27 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Bodenrader Mark See Remarks | 19,284 | $0 | 17,724 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 8:26 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Burgess Paul D. See Remarks | 23,847 | $0 | 45,727 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 8:24 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | DiPietro Kenneth Chief Human Resources Officer | 13,913 | $0 | 24,663 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 8:21 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Akamine Scott Chief Legal Officer | 13,796 | $0 | 7,237 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 8:18 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renaud Ronald C JR President & CEO | 160,452 | $0 | 244,309 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 8:14 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer | 24,825 | $0 | 14,673 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 8:12 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | ALTSCHULLER Susan Chief Financial Officer | 30,721 | $0 | 16,913 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 8:10 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Tregoning Kathleen See Remarks | 13,804 | $0 | 7,516 (Direct) | View |